Probity Advisors, Inc. Abb Vie Inc. Transaction History

Probity Advisors, Inc.

$515 Million
Q3 2024

A detailed history of Probity Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Probity Advisors, Inc. holds 13,895 shares of ABBV stock, worth $2.44 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

13,895

Previous 14,183 2.03%

Holding current value

$2.44 Million

Previous $2.43 Million 12.79%

% of portfolio

0.53%

Previous 0.51%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$163.84 - $199.33 $47,185 - $57,407	-288 Reduced 2.03%	13,895 $2.74 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $84,979 - $99,237	-549 Reduced 3.73%	14,183 $2.43 Million
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $86,462 - $98,516	-541 Reduced 3.54%	14,732 $2.68 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $44,857 - $50,520	-326 Reduced 2.09%	15,273 $2.37 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $15,630 - $18,094	117 Added 0.76%	15,599 $2.33 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $2,120 - $2,638	-16 Reduced 0.1%	15,482 $2.09 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $74,549 - $89,403	-539 Reduced 3.36%	15,498 $2.51 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $239,028 - $274,149	-1,781 Reduced 10.0%	16,037 $2.15 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $78,030 - $99,202	-567 Reduced 3.08%	17,818 $2.73 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $256,041 - $317,675	-1,940 Reduced 9.54%	18,385 $2.98 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $40,178 - $50,837	-374 Reduced 1.81%	20,325 $2.75 Million
Q3 2021 Oct 08, 2021	SELL	$106.4 - $120.78 $80,651 - $91,551	-758 Reduced 3.53%	20,699 $2.23 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $28,406 - $31,646	-270 Reduced 1.24%	21,457 $2.42 Million
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $26,904 - $29,619	263 Added 1.23%	21,727 $2.35 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $13,144 - $15,426	-153 Reduced 0.71%	21,464 $1.88 Million
Q2 2020 Aug 03, 2020	SELL	$73.37 - $98.18 $1.54 Million - $2.06 Million	-21,012 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $8,320 - $12,614	-129 Reduced 0.61%	21,012 $1.6 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $87,060 - $108,931	-1,207 Reduced 5.4%	21,141 $1.87 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $2,015 - $2,423	32 Added 0.14%	22,348 $1.69 Million
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $22,732 - $29,057	-346 Reduced 1.53%	22,316 $1.62 Million
Q1 2019 Apr 29, 2019	BUY	$77.14 - $90.79 $51,066 - $60,102	662 Added 3.01%	22,662 $1.83 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $27,013 - $33,315	-347 Reduced 1.55%	22,000 $2.03 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $24,628 - $27,378	-277 Reduced 1.22%	22,347 $2.11 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $14,903 - $17,634	166 Added 0.74%	22,624 $2.1 Million
Q1 2018 Apr 16, 2018	SELL	$92.01 - $123.21 $109,583 - $146,743	-1,191 Reduced 5.04%	22,458 $2.13 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $102,635 - $112,548	-1,146 Reduced 4.62%	23,649 $2.29 Million
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $1.73 Million - $2.21 Million	24,795	24,795 $2.2 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.

Account

Probity Advisors, Inc. Abb Vie Inc. Transaction History